DE602006018145D1 - Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisse - Google Patents
Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisseInfo
- Publication number
- DE602006018145D1 DE602006018145D1 DE602006018145T DE602006018145T DE602006018145D1 DE 602006018145 D1 DE602006018145 D1 DE 602006018145D1 DE 602006018145 T DE602006018145 T DE 602006018145T DE 602006018145 T DE602006018145 T DE 602006018145T DE 602006018145 D1 DE602006018145 D1 DE 602006018145D1
- Authority
- DE
- Germany
- Prior art keywords
- diagnosis
- treatment
- cerebrovascular events
- peptides based
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 239000013060 biological fluid Substances 0.000 abstract 1
- 230000007213 cerebrovascular event Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 238000002610 neuroimaging Methods 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
- 238000012502 risk assessment Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68980605P | 2005-06-13 | 2005-06-13 | |
| PCT/US2006/023020 WO2006135893A2 (en) | 2005-06-13 | 2006-06-13 | Methods for diagnosing and treating cerebrovascular events based on nr2 peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006018145D1 true DE602006018145D1 (de) | 2010-12-23 |
Family
ID=37532899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006018145T Active DE602006018145D1 (de) | 2005-06-13 | 2006-06-13 | Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisse |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20060281135A1 (de) |
| EP (1) | EP1899726B1 (de) |
| JP (1) | JP2008547002A (de) |
| CN (1) | CN101268370A (de) |
| AT (1) | ATE487947T1 (de) |
| CA (1) | CA2610833A1 (de) |
| DE (1) | DE602006018145D1 (de) |
| RU (1) | RU2008101419A (de) |
| WO (1) | WO2006135893A2 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6896872B2 (en) | 2001-06-27 | 2005-05-24 | Svetlana A. Dambinova | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke |
| US20060257943A1 (en) * | 2005-01-25 | 2006-11-16 | Cis Biotech, Inc. | Ischemic biomarkers and their use to predict adverse neurological events from surgery |
| US20080081980A1 (en) * | 2006-09-18 | 2008-04-03 | Michael Maschke | Apparatus and process for stroke examination and treatment using a C-arch X-ray system |
| US9958442B2 (en) | 2009-02-11 | 2018-05-01 | Duke University | Sensors incorporating antibodies and methods of making and using the same |
| WO2014160431A1 (en) | 2013-03-13 | 2014-10-02 | Health Diagnostic Laboratory, Inc. | Method of determining prior history of ischemic stroke for current risk evaluation and therapy guidance |
| WO2015187227A2 (en) | 2014-03-13 | 2015-12-10 | Duke University | Electronic platform for sensing and control of electrochemical reactions |
| RU2668534C1 (ru) * | 2017-07-18 | 2018-10-01 | Общество с ограниченной ответственностью "ДРД" | Диагностический набор реагентов для выявления хронических патологий мозга ишемического генеза |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08509607A (ja) * | 1993-04-20 | 1996-10-15 | ザ ソールク インスチチュート バイオテクノロジー／インダストリアル アソシエイツ，インコーポレイテッド | ヒトｎ−メチル−ｄ−アスパラギン酸受容体サブユニット、これをコードする核酸およびその用途 |
| WO2002012892A2 (en) | 2000-08-04 | 2002-02-14 | Cis Biotech, Inc. | Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke |
| US6896872B2 (en) | 2001-06-27 | 2005-05-24 | Svetlana A. Dambinova | Rapid multiple panel of biomarkers in laboratory blood tests for TIA/stroke |
| JP4838140B2 (ja) * | 2003-11-06 | 2011-12-14 | グレース ラボラトリーズ，インコーポレイティド | 発作性脳発射を評価するための免疫吸着血液検査 |
-
2006
- 2006-06-13 EP EP06773062A patent/EP1899726B1/de not_active Not-in-force
- 2006-06-13 US US11/451,679 patent/US20060281135A1/en not_active Abandoned
- 2006-06-13 US US11/916,507 patent/US8084225B2/en not_active Expired - Fee Related
- 2006-06-13 JP JP2008517026A patent/JP2008547002A/ja active Pending
- 2006-06-13 CA CA002610833A patent/CA2610833A1/en not_active Abandoned
- 2006-06-13 AT AT06773062T patent/ATE487947T1/de not_active IP Right Cessation
- 2006-06-13 CN CNA2006800293557A patent/CN101268370A/zh active Pending
- 2006-06-13 RU RU2008101419/15A patent/RU2008101419A/ru not_active Application Discontinuation
- 2006-06-13 DE DE602006018145T patent/DE602006018145D1/de active Active
- 2006-06-13 WO PCT/US2006/023020 patent/WO2006135893A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006135893A2 (en) | 2006-12-21 |
| US8084225B2 (en) | 2011-12-27 |
| CN101268370A (zh) | 2008-09-17 |
| RU2008101419A (ru) | 2009-07-20 |
| EP1899726B1 (de) | 2010-11-10 |
| WO2006135893A3 (en) | 2007-03-01 |
| JP2008547002A (ja) | 2008-12-25 |
| ATE487947T1 (de) | 2010-11-15 |
| US20060281135A1 (en) | 2006-12-14 |
| EP1899726A4 (de) | 2009-02-25 |
| CA2610833A1 (en) | 2006-12-21 |
| US20090181006A1 (en) | 2009-07-16 |
| EP1899726A2 (de) | 2008-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006018145D1 (de) | Verfahren zur diagnose und behandlung auf nr2-peptiden beruhender zerebrovaskulärer ereignisse | |
| DE602005024639D1 (de) | Verfahren und Gerät zur Diagnose des Ermüdungsversagens von Turboladern | |
| ATE493649T1 (de) | Verfahren zur diagnose von polyzystischer nierenkrankheit | |
| ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
| WO2008146309A3 (en) | Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment | |
| WO2013063155A3 (en) | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | |
| WO2008091814A3 (en) | Assessment of asthma and allergen-dependent gene expression | |
| CY1119262T1 (el) | Αναλυτικες μεθοδοι και συστοιχιες για χρηση στην ταυτοποιηση παραγοντων που επαγουν ευαισθητοποιηση στο ανθρωπινο δερμα | |
| WO2012054639A3 (en) | Nmr systems and methods for the rapid detection of analytes | |
| WO2006073682A3 (en) | Diagnostic test | |
| EP2924440A3 (de) | Mit arteriovaskulären ereignissen assoziierte marker und verfahren zur verwendung davon | |
| DE112006000054A5 (de) | Verfahren zur Diagnose eines Abgasnachbehandlungssystems | |
| BRPI0915240A2 (pt) | método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met | |
| DE60329165D1 (de) | Detektion und/oder beobachtung von synuclein-assoziierten krankheiten | |
| MX2009013649A (es) | Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma. | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| BR112012009846B8 (pt) | método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige | |
| WO2008137838A3 (en) | Interferon alpha-induced pharmacodynamic markers | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| DE602006014106D1 (de) | Verfahren zur diagnose von prostatakrebs | |
| DE602006009786D1 (de) | Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten | |
| DE602006013143D1 (de) | Verfahren zum nachweis aggregatbildender zirkulierender proteinformen und mittel zum einfangen gebildeter aggregate | |
| EP3839068A3 (de) | Verfahren zur behandlung, diagnose und überwachung von lupus | |
| ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
| ATE553127T1 (de) | Oligoklonale anti-clusterin-antikörper zur diagnose und vorhersage der aggressivität von tumoren, diagnostisches verfahren und damit in zusammenhang stehende kits |